| 1994 |
The yeast nuclear gene MRP-L13 encodes a mitochondrial ribosomal large subunit protein (YmL13) that is imported into mitochondria via an 86-amino-acid N-terminal signal peptide (the longest among known yeast mitochondrial ribosomal proteins). Disruption of MRP-L13 by LEU2 insertion impaired growth on non-fermentable carbon sources, establishing its role in mitochondrial function. Transcription of MRP-L13 is repressed by glucose. |
Gene cloning, N-terminal protein sequencing, gene disruption (LEU2 insertion), growth phenotype on non-fermentable carbon sources |
Current genetics |
Medium |
7954901
|
| 2021 |
RNAi-mediated knockdown of MRPL13 in breast cancer cells inhibited proliferation, migration, and EMT-related gene expression, and significantly suppressed phosphorylation of AKT and mTOR; this suppression was partially rescued by the PI3K agonist 740Y-P, placing MRPL13 upstream of PI3K/AKT/mTOR signaling. |
RNAi knockdown in BC cell lines, Western blot for pAKT/pmTOR, pharmacological rescue with PI3K agonist 740Y-P, proliferation and migration assays |
Cancer management and research |
Medium |
33658859
|
| 2025 |
MRPL13 specifically interacts with SLC25A6 (ANT3) and promotes its degradation via K48-linked ubiquitination. This interaction inhibits mitochondrial permeability transition pore (mPTP) opening, prevents cytochrome c release into the cytoplasm, and thereby inhibits cell death while enhancing mitochondrial OXPHOS and ATP production in ovarian cancer cells. MRPL13 knockdown caused decreased OXPHOS/ATP, increased ROS, mitochondrial depolarization, aberrant mPTP opening, and mitochondrial structural damage. |
Co-immunoprecipitation, ubiquitination assay (K48-linkage), MRPL13 knockdown/overexpression in vitro and in vivo, measurement of OXPHOS, ATP, ROS, mitochondrial membrane potential, cytochrome c release, mPTP opening assays |
Cell death & disease |
High |
40841355
|
| 2026 |
In zebrafish, loss of Mrpl13 disrupts mitochondrial homeostasis (fragmented mitochondria, impaired energy metabolism, excessive ROS, lipid accumulation) and causes liver developmental defects. Loss of Mrpl13 activates mTORC1 signaling, and pharmacological inhibition of mTORC1 with rapamycin significantly rescues the liver developmental defects, placing Mrpl13 upstream of mTORC1 in a regulatory axis controlling mitochondrial homeostasis during liver development. |
Zebrafish mrpl13 loss-of-function model, mitochondrial morphology and function assays (ROS, energy metabolism, lipid staining), mTORC1 activity measurement, rapamycin rescue experiment, liver developmental phenotype quantification |
Communications biology |
Medium |
42062477
|
| 2026 |
MRPL13 knockdown in human trophoblast cell lines (HTR8/SVneo and BeWo) triggers the mitochondrial unfolded protein response (UPRmt), depletes HSP60 and CLPP, aggravates mitochondrial dysfunction, inhibits cell migration, and enhances autophagy. Under tunicamycin-induced ER stress, MRPL13 knockdown further depletes HSP60/CLPP and worsens UPRmt, establishing MRPL13 as a regulator of UPRmt in trophoblasts. |
siRNA knockdown in HTR8/SVneo and BeWo cell lines, Western blotting, immunofluorescence, mitochondrial function assays, migration/proliferation/invasion assays, tunicamycin-induced ER stress model, proteomic sequencing of EOPE placentas |
Reproduction (Cambridge, England) |
Medium |
41630109
|